BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21418073)

  • 1. Are neuroleptic malignant syndrome and serotonin syndrome the same syndrome?
    Steele D; Keltner NL; McGuiness TM
    Perspect Psychiatr Care; 2011 Jan; 47(1):58-62. PubMed ID: 21418073
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin syndrome and atypical antipsychotics.
    Duggal HS; Fetchko J
    Am J Psychiatry; 2002 Apr; 159(4):672-3. PubMed ID: 11925312
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Sokoro AA; Zivot J; Ariano RE
    Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroleptic malignant syndrome].
    Bryois C; Bondolfi G
    Rev Med Suisse Romande; 1996 Sep; 116(9):713-7. PubMed ID: 8966472
    [No Abstract]   [Full Text] [Related]  

  • 5. [The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam].
    Real Rodríguez B; Ruibal JL; Grande Rodríguez S; Sueiro Pita B
    An Esp Pediatr; 1996 Jan; 44(1):60-2. PubMed ID: 8849063
    [No Abstract]   [Full Text] [Related]  

  • 6. Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death.
    Kline SS; Mauro LS; Scala-Barnett DM; Zick D
    Clin Pharm; 1989 Jul; 8(7):510-4. PubMed ID: 2568897
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome with use of quetiapine in mental retardation.
    Dan A; Bharadwaj R; Grover S
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):255-6. PubMed ID: 19335404
    [No Abstract]   [Full Text] [Related]  

  • 8. The evaluation and management of patients with neuroleptic malignant syndrome.
    Bhanushali MJ; Tuite PJ
    Neurol Clin; 2004 May; 22(2):389-411. PubMed ID: 15062519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin syndrome overlapping with neuroleptic malignant syndrome: A case report and approaches for differentially diagnosing the two syndromes.
    Nisijima K
    Asian J Psychiatr; 2015 Dec; 18():100-1. PubMed ID: 26506919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics.
    Hatch CD; Lund BC; Perry PJ
    Pharmacotherapy; 2001 Aug; 21(8):1003-6. PubMed ID: 11718487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Depressive stupor--malignant neuroleptic syndrome--serotonin syndrome. A case contribution to a difficult differential diagnosis].
    König F; Löble M; Wolfersdorf M
    Nervenarzt; 1996 May; 67(5):407-12. PubMed ID: 9005353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin syndrome and other serotonergic disorders.
    Ener RA; Meglathery SB; Van Decker WA; Gallagher RM
    Pain Med; 2003 Mar; 4(1):63-74. PubMed ID: 12873279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome and catatonia. A report of three cases.
    Raja M; Altavista MC; Cavallari S; Lubich L
    Eur Arch Psychiatry Clin Neurosci; 1994; 243(6):299-303. PubMed ID: 7913834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case reports of neuroleptic malignant syndrome in context of quetiapine use.
    Detweiler MB; Sullivan K; Sharma TR; Kim KY; Detweiler JG
    Psychiatr Q; 2013 Dec; 84(4):523-41. PubMed ID: 23686527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical neuroleptic malignant syndrome with quetiapine: a case report and review of the literature.
    El-Gaaly S; St John P; Dunsmore S; Bolton JM
    J Clin Psychopharmacol; 2009 Oct; 29(5):497-9. PubMed ID: 19745653
    [No Abstract]   [Full Text] [Related]  

  • 16. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
    Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
    Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myoglobinuric renal failure. A consequence of the neuroleptic malignant syndrome.
    Eiser AR; Neff MS; Slifkin RF
    Arch Intern Med; 1982 Mar; 142(3):601-3. PubMed ID: 6121542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroleptic malignant syndrome].
    Charra B; Nejmi H; Hachimi A; Benslama A; Motaouakkil S
    Ann Fr Anesth Reanim; 2006 May; 25(5):542-3. PubMed ID: 16488105
    [No Abstract]   [Full Text] [Related]  

  • 19. Mirtazapine: unable to induce serotonin toxicity?
    Gillman PK
    Clin Neuropharmacol; 2003; 26(6):288-9; author reply 289-90. PubMed ID: 14646604
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse reactions to mirtazapine are unlikely to be serotonin toxicity.
    Isbister GK; Whyte IM
    Clin Neuropharmacol; 2003; 26(6):287-8; author reply 289-90. PubMed ID: 14646603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.